| UNIVERSITAT ZU KOLN Patent applications |
| Patent application number | Title | Published |
|---|
| 20110097334 | Novel Marker Genes for Regulatory T Cells from Human Blood - The present invention provides novel marker genes for the specific identification and characterization of human suppressive and/or regulatory T cells including natural, adaptive, and expanded CD4 | 04-28-2011 |
| 20110023181 | Means for Improving Agrobiological Traits in a Plant by Providiing a Plant Cell Comprising in its Chloroplasts Enzymatic Activities for Converting Glycolate Into Malate - The present invention is concerned with the improvement of aghcobiological traits in plants. More specifically, it relates to a plant cell comprising in its chloroplasts enzymatic activities for converting glycolate into malate. Preferably, said plant cell comprises a first polypeptide having glycolat oxidase activity, a second polypeptide having malate synthase activity and a third polypeptide having catalase activity or a first polypeptide having glycolat dehydrogenase activity and a second polypeptide having malate synthase activity. Also encompassed is a plant comprising said plant cells as well as seeds obtainable from the said plants. The present invention, furthermore, relates to a method for producing a transgenic plant or a plant cell having an increased water use efficiency or increased yield. The present invention contemplates polynucleotides comprising a combination of nucleic acids encoding the aforementioned polypeptides as well as vectors comprising the polynucleotides and uses thereof. | 01-27-2011 |
| 20090214431 | IDENTIFICATION OF ERGOTHIONEINE TRANSPORTER AND THERAPEUTIC USES THEREOF - The transporter that translocates ergothioneine has been identified. Described are methods for identifying and obtaining compounds capable of modulating ergothioneine transport as well as the use of such compounds for the treatment of diseases ergothioneine may be involved in such as autoimmune diseases, in particular rheumatoid arthritis, as well as other diseases arising from cell damage caused by radiation, radicals and relative oxidant species. Furthermore, diagnostic means and methods for determining the presence or susceptibility to such a disease are provided. | 08-27-2009 |
